A phase 2, multicentre, single-arm, open-label study to...

European Journal of Cancer 2013 / 9 Vol. 49; Iss. 13

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

Morschhauser, Franck, Fitoussi, Olivier, Haioun, Corinne, Thieblemont, Catherine, Quach, Hang, Delarue, Richard, Glaisner, Sylvie, Gabarre, Jean, Bosly, André, Lister, John, Li, Ju, Coiffier, Bertrand
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2013.04.029
Date:
September, 2013
File:
PDF, 467 KB
english, 2013
Conversion to is in progress
Conversion to is failed